Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
BMJ Open ; 7(6): e013744, 2017 06 23.
Artigo em Inglês | MEDLINE | ID: mdl-28645949

RESUMO

INTRODUCTION: In order to reduce cardiovascular disease risk factors, a healthy diet must include dietary antioxidants from different sources (eg, Spirulina maxima) and regular practice of exercise should be promoted. There is some evidence from animal studies that S. maxima and exercise decrease cardiovascular disease risks factors. However, very few studies have proved the independent or synergistic effect of S. maxima plus exercise in humans. This study attempts to address the independent and synergistic effects in overweight and obese subjects participating in a systematic physical exercise programme at moderate intensity on general fitness, plasma lipid profile and antioxidant capacity. METHODS AND ANALYSIS: Using a randomised, double-blind, placebo-controlled, counterbalanced crossover study design, 80 healthy overweight and obese subjects will be evaluated during a 12-week isoenergetic diet accompanied by 4.5 g/day S. maxima intake and/or a physical systematic exercise programme at moderate intensity. Body composition, oxygen uptake, heart rate, capillary blood lactate, plasma concentrations of triacylglycerols, total, low-density and high-density lipoprotein cholesterol, antioxidant status, lipid oxidation, protein carbonyls, superoxide dismutase, catalase, glutathione, glutathione peroxidase, glutathione reductase and paraoxonase will be assessed. ETHICS AND DISSEMINATION: This study and all the procedures have been approved by the Universidad Autonoma de Ciudad Juarez Bioethics Committee. Findings will be disseminated through peer-reviewed journals, national and international conferences. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov: NCT02837666.


Assuntos
Exercício Físico , Lipídeos/sangue , Obesidade/terapia , Sobrepeso/terapia , Spirulina , Adolescente , Adulto , Antioxidantes/metabolismo , Composição Corporal , Índice de Massa Corporal , Doenças Cardiovasculares/prevenção & controle , Estudos Cross-Over , Suplementos Nutricionais , Método Duplo-Cego , Feminino , Humanos , Masculino , México , Estresse Oxidativo/efeitos dos fármacos , Aptidão Física , Projetos de Pesquisa , Adulto Jovem
2.
Nutr. hosp ; 32(2): 545-555, ago. 2015. ilus, tab
Artigo em Espanhol | IBECS | ID: ibc-139985

RESUMO

La principal función de los adipocitos es el almacenamiento de lípidos cuando hay exceso de energía y la movilización de la misma cuando hay deficiencia. Una de las características de la obesidad es el aumento de la cantidad y el tamaño de los adipocitos, lo que implica la diferenciación de preadipocitos (PAD). El tejido adiposo (TA) tiene su origen en la etapa prenatal y puede seguir expandiéndose durante la vida adulta a partir de células precursoras, ya que los adipocitos maduros no pueden multiplicarse por división celular. El presente estudio proveerá información reciente de los eventos que se producen durante el origen y diferenciación de los PAD, así como los factores implicados en la regulación de la adipogénesis y los mecanismos que regulan las funciones fisiológicas del TA (AU)


The main function of the adipocyte is lipid storage when there is a positive energy balance and lipid release when there is and energy deficiency. One characteristic of obesity is an increase in the number and size of adipocytes, which implies pre adipocyte (PAD) differentiation. The adipose tissue (AT) has its origins in the prenatal stage and may continue to expand during adulthood from precursor cells since mature adipocytes cannot multiply by cell division. This study provide updates on the events that occur during the origin and differentiation of PAD, the factors involved in the regulation of adipogenesis and mechanisms that regulate physiological functions of AT (AU)


Assuntos
Feminino , Humanos , Masculino , Adipogenia , Tratamento Farmacológico/organização & administração , Fitoterapia/métodos , Adipócitos , Células-Tronco , Diferenciação Celular , Alcaloides/uso terapêutico , Etnofarmacologia/métodos , Receptores de Citocinas , Receptores de Citocinas/uso terapêutico , Inflamação/tratamento farmacológico , Obesidade/tratamento farmacológico , Fármacos Antiobesidade/efeitos adversos , Fármacos Antiobesidade/uso terapêutico , Nelumbo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...